Distribution and Molecular Characterization of Acinetobacter baumannii International Clone II Lineage in Japan
ABSTRACTMultidrug-resistant (MDR)Acinetobacterspp. have been globally disseminated in association with the successful clonal lineageAcinetobacter baumanniiinternational clone II (IC II). Because the prevalence of MDRAcinetobacterspp. in Japan remains very low, we characterized allAcinetobacterspp. (n= 866) from 76 hospitals between October 2012 and March 2013 to describe the entire molecular epidemiology ofAcinetobacterspp. The most prevalent species wasA. baumannii(n= 645; 74.5%), withA. baumanniiIC II (n= 245) accounting for 28.3% of the total. Meropenem-resistant isolates accounted for 2.0% (n= 17) and carried ISAba1-blaOXA-23-like(n= 10),blaIMP(n= 4), or ISAba1-blaOXA-51-like(n= 3). Multilocus sequence typing of 110 representativeA. baumanniiisolates revealed the considerable prevalence of domestic sequence types (STs).A. baumanniiIC II isolates were divided into the domestic sequence type 469 (ST469) (n= 18) and the globally disseminated STs ST208 (n= 14) and ST219 (n= 4). ST469 isolates were susceptible to more antimicrobial agents, while ST208 and ST219 overproduced the intrinsic AmpC β-lactamase.A. baumanniiIC II and someA. baumanniinon-IC II STs (e.g., ST149 and ST246) were associated with fluoroquinolone resistance. This study revealed that carbapenem-susceptibleA. baumanniiIC II was moderately disseminated in Japan. The low prevalence of acquired carbapenemase genes and presence of domestic STs could contribute to the low prevalence of MDRA. baumannii. A similar epidemiology might have appeared before the global dissemination of MDR epidemic lineages. In addition, fluoroquinolone resistance associated withA. baumanniiIC II may provide insight into the significance ofA. baumanniiepidemic clones.